CHP
NEOS

Cable Hill Partners’s Neos Therapeutics, Inc NEOS Stock Holding History

Cable Hill Partners’s Portfolio NEOS Stock Details NEOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-568
Closed -$3K – 864
2018
Q3 		$3K Hold
568
– – ﹤0.01% 686
2018
Q2 		$4K Sell
568
-1,000
-64% -$7.46K ﹤0.01% 750
2018
Q1 		$13K Hold
1,568
– – 0.01% 430
2017
Q4 		$16K Hold
1,568
– – 0.01% 476
2017
Q3 		$14K Buy
1,568
+1,000
+176% +$7.6K 0.01% 502
2017
Q2 		$4K Hold
568
– – ﹤0.01% 614
2017
Q1 		$4K Hold
568
– – ﹤0.01% 603
2016
Q4 		$3K Hold
568
– – ﹤0.01% 634
2016
Q3 		$4K Buy
+568
New +$4.5K ﹤0.01% 639

Other funds holding NEOS

NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JGC
J. Goldman & Co New York $3.44B AUM 33.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Cable Hill Partners's NEOS Position: Q4 2018 in Review

Cable Hill Partners sold out of Neos Therapeutics, Inc (NEOS) in Q4 2018, closing a stake of 568 shares — an estimated $3K sold.

Cable Hill Partners first reported a position in NEOS in Q3 2016 and held it in 9 quarters. The position peaked at $16K in Q4 2017. 63 funds tracked by Wall St. Rank hold NEOS as of Q4 2018.

  • Cable Hill Partners reported no remaining Neos Therapeutics, Inc position as of Q4 2018 after selling out during the quarter.
  • Cable Hill Partners sold 568 Neos Therapeutics, Inc shares in Q4 2018, an estimated $3K.
  • Cable Hill Partners first reported a position in Neos Therapeutics, Inc in Q3 2016 and held it in 9 quarters.
  • Cable Hill Partners's Neos Therapeutics, Inc position peaked at $16K in Q4 2017.
  • 63 funds tracked by Wall St. Rank held Neos Therapeutics, Inc as of Q4 2018.

Based on Cable Hill Partners's 13F filing for Q4 2018, filed 12 Feb 2019.